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The  existence of antigenic differences among  the virus agents of influenza 
is now  a  generally accepted fact.  The  difference between  the  so called  "A 
group" and the so called "B group" is commonly taken into account, but the 
differences within the "groups" have in general been considered to be of little 
practical importance.  The purpose of the present paper is to report data which 
show that  in some instances the antigenic differences among strains belonging 
to the "A group" are of sufficient magnitude to warrant their being taken into 
consideration in all problems dealing with the immunity and epidemiology of 
influenza. 
Methods and Materials 
The investigation consisted of mouse protection tests with serums from 40 influenza 
patients, against 7  different strains of virus.  Two  strains,  PR8  (1)  and  TM  (2), 
were  established  laboratory strains, representative  of "group  A" and  "group  B." 
The other 5 strains CC, AN, KD, MR, and VH are of special interest because they 
had  been isolated during the outbreak studied in  the investigation; in the present 
paper they are referred to as the "1941  strains."  These strains, although certainly 
not identical, do have some antigenic relationship to each other and to the PR8 and 
would, therefore, be included within the "A group"; their antigenic properties have 
been described previously (3). 
The  serums were from patients who  had  influenza during an  outbreak that oc- 
curred during January and February, 1941, among the nurses of The New York Hos- 
pital.  Two samples of serum were obtained from each person: the first was  gotten 
within the first few days of the time of onset of illness; and the second, 2 to 3 weeks 
later. 
The  virus suspensions used  in the tests contained, in the  case of the 5  recently 
isolated strains and also in the case of TM, approximately 500  lethal doses for mice, 
per inoculated dose; in the case of PR8 the suspensions contained approximately 1000 
lethal doses.  The serums were tested in 2 lots.  Each lot, or approximately half  of 
the total number of pairs were tested at the same time in the same experiment against 
a suspension of one of the strains of virus.  Each serum was tested in a  series of three- 
fold dilutions.  Mixtures of 0.2 cc. Of virus suspension and 0.2 cc. of serum  dilution 
were incubated at 37°C. for 30 minutes, after which 0.05 cc. to 0.06 cc. quantities were 
dropped into the nostrils of groups of 3 lightly ether-anesthetized Swiss mice.  TI~ 
tests were  terminated on  the 9th  day. 
1 TABLE  I 
Results of Protection Tests of Serums from  40 Patients against 7 Strains of Influenza  Virus 
(The  titres are expressed in  terms of the dilution of serum which protected  50 per cent 
of the mice from death.) 
Patie~at 
Titres at time of onset of illness 
PR, 
1.  J.C ...........  79 
2.  P.M ..........  19 
3.  H.J ...........  17 
4.  L. W.. : .......  35 
5.  B.D ..........  19 
6.  R. K. .........  21 
7.  C.'C.*.  ........  10 
8.  :E.J~...  ........  10 
9.  M. H.: ........  10 
10.  J. N ...........  20 
II.  j. H., ..........  19 
12.  D.K.  19 
13.  EV.  R.......  37 
14.  P. E ...........  42 
15.  M. G .........  87 
16. C,,.u .........  8 
17.  M.T .........  8 
18.  M.L .........  8 
19.  A.S..  ...  8 
20. J. M ..........  8 
:21.:  E.R.  .........  8 
22,  R.  R .........  8 
~3.:. E.-M...  : ....  8 
~-4. L. C ..........  4 
25:.  E. G .........  4  I  2 
Strain of virus 
0 
•  20  12 
•  21  2 
•  41  15 
26,  a.~.,  .......  4 
22.  ~,B  ........  2 
28.  M.  W  .........  0 
29. M.  R:  *~ .  0 
30.  B.H.  ...... '...  0 
.3t.  A.R  ..........  0 
3~.  R.T ..........  0 
33.  A.L ..... .....  0 
34.  V. H.* ........  0 
35. K.  D.* ........  0 
36,  B. J ..........  0 
.  ,.i 
37., M. c.:  ......  o 
38.  A.B ......... 
39, B.' MI. i ..... 
40.  M.  J'..':...... 
CC  AN  KD  MR  VH 
0  0  0  4  0 
Oi  0  0  0  0 
0~  0  6  5~  16 
521  2  2  2  16 
5  18  2  8 
2  I  2  6  4[  4 
01  5  18  2  I0 
o  o  o  ol5 
01  0  2  2]  0 
2  7  30  7135 
5  15  18  5]  25 
i 
5  5  18  7  ]  16 
I 
.5  15  20  16  f  16 
155  5  62  16  ]143 
9[15154  21141 
2  4  7  5  8 
0  5  20  5  20 
0  0  0  0  9 
0  0  0  2  16 
0  0  0  2  0 
0  0  0  2  2 
2  5  18  0  19 
0  2  6  2.  12 
0  0  20  0  0 
0  2  0  8 
0  0  0  0  i  0  0  4  19  5  5 
o  o  6  o 
0  0  6  0 
0  0  0  0 
0  0  0  0  2 
0  0  0  0  0 
0  0  0  0  0 
0  0  0  0  0 
0  0  0  0  0 
0  0  0  0  0 
0  0  0  0 
15  36  7  81 
2  6  5  12 
12  554  12  142 
Titres 2 to 3 weeks after illness 
Strain of virus 
TM  ?iY  PR8 
2 
21 
t6  I 
5 
2 
2 
ol 
2 
0 
2 
55 
3 
0 
0 
2 
21 
2  t  87 
0i  90 
ol  87 
2  250 
2  190 
0  19 
0  30 
0  79 
.2  2550 
0  9 
0  87 
2  87 
0  35 
0  87 
0  78 
2  39 
2  37 
0  19  ol :°t 
o  °  30 
250 
411 
250l 
255501 
255501 
87 
981 
191 
25501 
87 
981 
250[ 
98 
I 
1501 
~'C  AN  KD  MR  ! VH 
.'  18  3!  15 
1~  161  54  21  11C 
4;  47l  1621 14~  14(] 
1¢  15[  361  9~  11(] 
.4~  110l  2431 24~  17(] 
4~  47[  1621  4;  142 
6.~  ll0l  2431  1(  125 
~:  :.:  181  .:  47 
1~  16l  57  41  87 
62  631  2431  6~  243 
4~  62[  162  47  125 
62  ll01  162  6~  243 
47  471  162  47  62 
21  471  162  41  240 
47  471  162[  62  170 
42  1431 192  42  250 
15  37l  160  41  110 
16  16[  54  37  142 
21  16[  54  47  143 
2  12[  54  47  62 
12  16]  18[  47  110 
.5  12[  81[  7  47 
16  15[  145  21  62 
47  16l  160  47  79 
4,3  143l  243  47  250 
12  15l  54  16  142 
3,1  110l  170  142  110 
.5  ~'  162  47  110 
C  OI  20  7  5 
5  514  12  5 
.5  51  7  16  47 
21  16[  54  1(~  110 
16  5l  18  1¢~  110 
.5  21  6  4  17 
4  2',  91  2  10 
C  01  01  4  5 
C  OI  0[  £  0 
7  15]  554  12  78 
2  21  7  4  12 
12  15[  54[  1¢~  142 
2 
4 
16 
5 
2 
0 
0 
2 
0 
2 
7 
2 
0 
0 
2 
* Persons from whom strains of virus were isolated. 
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The data are presented in Table I, in which the titres are expressed  as the dilution 
of serum that would protect 50 per cent of the mice from death (4). 
RESULTS 
The data in Table I  show that  the calculated antibody titres, both of the 
"acute" and of the  "convalescent" samples, were influenced by the strain of 
virus used to test the serums.  The pronounced difference between the results 
obtained with the TM and with the PR8 would be expected.  However, marked 
differences were also manifest among all of the 6  "group A" strains, which is 
especially significant in view of the fact that 5 of these strains had been isolated 
from the same localized outbreak from which the serums had been obtained. 
This influence of the strain of virus upon the calculated antibody titre of the 
serums has an important bearing upon  two practical  problems: the question 
of the r61e of circulating antibodies in the mechanism of resistance to influenza 
infection; and the question of the serological diagnosis of influenza.  The data 
pertaining to these two questions will be considered separately. 
Titres at the Time of Onset of Illness.--It is apparent from the data (Table I) 
that serums obtained at the time of onset of illness may possess quite different 
protective  capacities against  different  although  related  strains  of virus.  In 
the case of patients 1 to 15 inclusive, the serums possessed an appreciably high 
(1-10 or more) protective antibody titre against the PR8, but in each instance 
the titre was significantly lower against one or another of the 1941 strains.  For 
example, in case 1 (J. C.), the serum when diluted as much as 1-79 protected 
mice against 1000 lethal doses of the PR8 strain, but even when undiluted  it 
failed to protect against 500 lethal doses of the CC, AN, KD, or VII strains. 
Also, in case 2 (P. M.), the serum protected against the PR8 when diluted 1-10 
but was devoid of protection against each of the five 1941 strains. 
The differences in  calculated antibody titres are evident not only in com- 
parisons of the various 1941 strains against the PR8 strain,  but also in com- 
parisons of the various 1941 strains against each other.  For example, in case 3 
(H. J.) the  serum was effective in dilution of 1-16 against  the VH strain, but 
had  no  demonstrable  protective  capacity against  either  the  CC  or the  AN 
strains.  In cases 10 and  17  (J. N., M.  T.), the serums had titres of 1-20 to 
1-35 when tested against the KD and VH strains but had little or no protective 
capacity against the CC strain.  Similarly, in case 14  (P. E.), the serum had 
titres as high as 1-62 and 1-143 against the KD and VH strains but had a titre 
of only 1-5 against the AN strain. 
The data from the 5 cases marked with an asterisk (Nos. 7, 26, 29, 34, and 35) 
deserve special attention because strains of virus had been isolated from those 
particular cases.  It is important that at the time of onset of illness the serum 
of none of these 5 patients had any demonstrable protective antibodies against 
the strictly homologous strain of virus.  The data in case 7 (CC)are of special 4  "A  GROUP"  OF  INFLUENZA  VIRUSES 
interest.  The serum obtained from that patient at the time of onset of her 
illness  had a titre of 1-18 against the KD strain and of 1-10 against both the 
VH and the PR8 strains,  so that if judged on the basis of tests against those 
strains this patient would appear to be an example of the occurrence of an in- 
fluenza infection in a  person having a  significant titre of antibodies; whereas, 
the tests with the homologous CC strain showed that this patient actually had 
no circulating antibodies reactive with the etiological agent of her infection. 
Antibody Increases Evoked by the Infections.--The data in Table I  show also 
that the detection of the antibody response is influenced by the strain of virus 
employed to test the serums.  The differences  in the ratios between the "con- 
valescent" and the "acute" samples  from the s~me person were often of con- 
TABLE  II 
Examples of Significant Antibody Response Against Some Strains  of Virus  but Not  against 
Other Antigenically Related Strains 
Ratio between the titre of the "convalescent"  sample and the titre of the 
"acute" sample 
Patient  Strain of virus 
CC  AN  KD  MR  VH 
2.  P.M ......... 
8.  E.J  .......... 
13.  Ev. R ........ 
26. A.N  .......... 
29.  M.R  ......... 
35.  K.D  ......... 
36.  B.J  .......... 
PR8 
41/19 
19/10 
62/37 
9/4 
35/0 
0/0 
3/0 
12/0 
5/0 
47/5 
12/0 
0/0 
4/0 
0/0 
16/0 
5/0 
47/15 
15/0 
0/0 
2/0 
0/0 
54/0 
18/o 
162/2o 
54/0 
20/6 
9/0 
0/0 
21/o 
5/0 
47/16 
16/0 
7/0 
2/0 
4/0 
11o/o 
47/5 
62/16 
142/0 
5/0 
lO/O 
5/0 
siderable magnitude.  However, the most interesting  examples are the 7 cases 
in which a  significant increase in the titre of the  "convalescent" sample was 
evident in the tests against some  of the strains,  but not in the tests  against 
other strains.  This point  can be shown conveniently by arranging the data 
from these 7 cases as in Tab]e II, in the form of the ratios between the titres of 
the  "acute" and  "convalescent" samples of serum.  It is evident  (Table II) 
that, in cases 2, 8,  13, 26, and 35, little or no  increase in titre was apparent in 
the tests against the PR8 strain, whereas very significant increases were evident 
in the tests against one or another (but not always all) of the five 1941 strains. 
On the other hand, in cases 29 and 36, significant increases  were shown in the 
tests against the PR8 and also against the MR and the VH strains but were not 
demonstrable in the tests against the CC and AN strains although the latter 
two strains were isolated from the  same outbreak as were  the  MR and  VH 
strains. THOMAS  P. I~AGILL AND  JOHN  Y. SUGG 
It is a  common practise to require for a  positive diagnosis of influenza, the 
demonstration of an increase at least threefold in the titre of serum antibodies. 
When the complete data in Table I  are examined on that basis, it is apparent 
that the number of cases which would be diagnosed as influenza would depend 
upon the strain of virus used to test the serums.  If the PR8 strain had been 
used alone, only 29 of the 40 cases would have been diagnosed; if either the CC 
or AN strains had been used alone, only 31 would have been diagnosed as in- 
fluenza.  The  MR  strain  seemed  to  have  the  broadest  range  of  reactivity 
since tests with it revealed significant antibody increases in 35  of the  cases. 
On the basis of the total tests utilizing all the  strains, 36 of the 40 cases would 
have been diagnosed; and, in fact, these 36 cases would have been diagnosed by 
several combinations of two strains. 
There remain however, 4 cases which showed  no antibody increases against 
any of the 7 strains included in the tests.  However, in the  absence of viruses 
isolated from these particular cases, it is impossible to determine whether these 
cases represent persons who failed for some reason to give an antibody response 
or whether they were infected by some agent not closely related to the strains 
used in the tests. 
DISCUSSION 
The  present  investigation  dealt  with  antigenic  differences  among  strains 
included within the so called "A  group" of  influenza viruses.  The existence 
of strain  differences has been  previously established  (5-7);  and  it  has :been 
recognized  that  the  differences  frequently  are  reflected  in  serums  obtained 
from influenza patients (8, 9).  Nevertheless, the practical significance of the 
antigenic differences among the "A group" of strains has been open to question 
because it has been apparent to all who have been concerned with the problem 
that the differences in many instances appear to be slight, and of limited sig- 
nificance.  The present data show, however, that in other instances the differ- 
ences are of sufficient magnitude to warrant their being taken into considera- 
tion in the various aspects of the general problem of influenza. 
The data show that the protective capacity of the serum against one strain 
of influenza virus is not necessarily a  true index of the protective capacity of 
that  serum against  other,  although  antigenically related  strains.  A  number 
of the serums obtained at the time of onset of illness possessed high protective 
antibody titres against some strains of virus, but not against other strains of 
the same group.  On the basis of that evidence it seems entirely possible that 
at the time of onset of illness a person may possess a high serum antibody titre 
against some heterologous test strain of virus, but at the same time have little, 
if any serum protective capacity against the strictly homologous strain, even 
though that strain is antigenically related to the heterologous test strain.  A 6  "A  GROUP"  OF  INFLUENZA  VIRUSES 
systematic effort was  made to obtain  conclusive information on that  point; 
but in spite of numerous attempts,  virus was  isolated from only one person 
whose serum at the time of onset of infection possessed appreciably high pro- 
tective antibody titres against the PR8, or other heterologous related strains 
included in the tests.  The data in that instance are of significance, because 
they showed that  the  "acute"  serum  possessed appreciably high  protective 
titres against the PR8 and against 2 of the 1941 strains, but exerted no demon- 
strable  protective capacity against  the  strictly homologous strain  of virus. 
That  evidence, obviously, is  insufficient to  establish  the  point  that  clinical 
influenza occurs only in persons possessing little or no serum protective capacity 
against the strain of virus actually responsible for the infection.  It is sufficient, 
however, to show that questions such as the one recently raised by Francis (10) 
concerning the r61e of circulating antibodies in the mechanism of resistance to 
influenza, can be answered only by the accumulation of evidence from experi- 
ments in  which the test  serums and test virus are obtained from the  same 
patient. 
The data show also that the response of protective antibodies evoked by an 
influenza infection may not be detected by tests of the serum against  some 
strains of influenza virus, but can readily be detected by other antigenically 
related strains.  That point is of practical importance from the standpoint of 
the serological diagnosis of influenza.  In the present investigation influenza 
would have been diagnosed in 36 of the 40 cases by tests against several com- 
binations of strains included within the "A group."  It seems significant, how- 
ever, that all 36 cases would not have been diagnosed on the basis of tests with 
any single one of the  strains  included. 
SLrMMARY 
"Acute" and  "convalescent" samples  of serum  from  40  patients  from  a 
localized outbreak  of influenza were  tested  for mouse-protective antibodies 
against 7 different strains of influenza virus, which included 2 laboratory strains 
representative of "group A" and of "group B," and 5 strains from the investi- 
gated outbreak.  The latter 5  strains although not identical were related to 
each other and to the PR8 strain.  The chief point shown by the data was the 
considerable degree of antigenic difference among  the  6  "group A"  strains, 
evidenced by the marked differences in the protective capacities of the serums 
when  tested  against  the  various strains. 
A  number of the  "acute" serums showed high protective capacity against 
some strains but relatively little protective capacity against other strains.  In 
the 5 instances in which it was possible to test the  "acute" serums against 
strictly homologous strains of virus, no protective capacity was demonstrable. 
In 7 of 36 cases, the antibody responses evoked by influenza infections were 
not detectable by tests with some strains, but were detectable by tests against 
other related strains. THOMAS P.  MAGILL AND JOHN Y.  SUGG 
BIBLIOGRAPHY 
1.  Francis, T., Jr., Science, 1934, 80, 457. 
2.  Magill,  T. P., Proc. Soc. Exp. Biol.  and  Med.,  1940, 45,  162. 
3.  Magill, T. P., and Sugg, J. Y., Proc. Soc. Exp. Biol. and Med., 1943, 53, 104. 
4.  Reed, L. J., and Muench, H., Am. J. Hyg., 1938, 9.7,493. 
5.  MagiU, T. P., and Francis, T., Jr., Proc. Soc. Exp. Biol. and Med., 1936, 35, 463. 
6.  MagiU, T. P., and Francis, T., Jr., Brit. J. Exp. Path.,  1938, 19,273. 
7.  Smith, W., and Andrewes, C. H., Brit. J. Exp. Path., 1938, 19, 293. 
8.  Magill, T. P., and Sugg, J. Y., Proc. 3rd Internat.  Cong. Microbiol., New York, 
1939, 379. 
9.  Taylor, R. M., and Dreguss, M., J. Infect. Dis., 1941, 68, 79. 
10.  Francis, T., Jr., The Harvey Lectures, 1941-1942, 37, 69. 